Departamento
CIENCIAS FARMACÉUTICAS
Publicaciones (12) Publicaciones en las que ha participado algún/a investigador/a
2024
-
Bioguided Assay of Polyphenols Isolated from Medicinal Mayan Species and its Activity Against Leishmania mexicana
Pharmacognosy Journal, Vol. 16, Núm. 1, pp. 174-180
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Therapeutic Advances in Gastroenterology, Vol. 17
-
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74
-
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
United European Gastroenterology Journal
-
Cytotoxic Cyclolignans Obtained by the Enlargement of the Cyclolignan Skeleton of Podophyllic Aldehyde, a Selective Podophyllotoxin-Derived Cyclolignan
Molecules, Vol. 29, Núm. 7
-
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259
-
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift?
Medicinal Research Reviews, Vol. 44, Núm. 3, pp. 1055-1120
-
Increased prevalence of migraine in women with inflammatory bowel disease: A cross-sectional study
Cephalalgia : an international journal of headache, Vol. 44, Núm. 3
-
New benzimidazole derivative compounds with in vitro fasciolicidal properties
Parasites and Vectors, Vol. 17, Núm. 1
-
Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies
Bioorganic Chemistry, Vol. 146
-
Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease
Digestive and Liver Disease, Vol. 56, Núm. 3, pp. 468-476
-
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients
Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182